Cardiac Pacemakers Market Report 2026

Cardiac Pacemakers Market Overview

• Cardiac Pacemakers market size has reached to $4.95 billion in 2025 • Expected to grow to $6.92 billion in 2030 at a compound annual growth rate (CAGR) of 6.9% • Growth Driver: Cardiovascular Diseases Fueling Growth Of The Cardiac Pacemaker Market • Market Trend: Innovative Dual-Chamber Pacemaker System With Real-Time Communication Technology • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Cardiac Pacemakers Market?

A cardiac pacemaker refers to a small electronic device that generates electrical impulses and prevents the heart from beating too fast or slow and helps in treating heart conditions such as arrhythmias is a heart condition where the heart beats irregularly. The cardiac pacemakers are used to maintain the rhythm of heartbeats. The main types of cardiac pacemakers include implantable and external implantable cardiac pacemakers is a device that generates electrical impulses to maintain the heart rate and are installed inside the chest through surgery. The different cardiac pacemaker technologies include biventricular, single-chambered, and dual-chambered. The cardiac pacemaker applications include arrhythmias, heart blockage, atrial fibrillation, long QT syndrome, congestive cardiac failure, and other applications used by end-users including clinics and hospitals, ambulatory surgical centers, and cardiac care centers.

What Is The Cardiac Pacemakers Market Growth Forecast?

The cardiac pacemakers market size is expected to see strong growth in the next few years. It will grow to $6.92 billion in 2030 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to increasing demand for remote patient monitoring, rising adoption of smart pacemakers, expansion of ambulatory cardiac procedures, growing focus on personalized cardiac therapy, increasing investments in cardiac digital health. Major trends in the forecast period include increasing adoption of leadless pacemakers, rising use of remote cardiac monitoring systems, growing preference for dual and biventricular devices, expansion of minimally invasive implantation techniques, enhanced focus on device longevity and safety.

Global Cardiac Pacemakers Market Segmentation

1) By Type: Implantable, External 2) By Technology: Biventricular, Single Chambered, Dual Chambered 3) By Application: Arrhythmias, Heart Blockage, Congestive Cardiac Failure, Other Applications 4) By End User: Clinics And Hospitals, Ambulatory Surgical Centers, Cardiac Care Centers Subsegments: 1) By Implantable: Single Chamber Pacemakers, Dual Chamber Pacemakers, Biventricular Pacemakers (CRT-P), Leadless Pacemakers 2) By External: Temporary External Pulse Generators, Transcutaneous External Pacemakers

What Is The Driver Of The Cardiac Pacemakers Market?

An increase in cardiovascular diseases is significantly contributing to the growth of the cardiac pacemaker market. Cardiovascular disease (CVD) refers to disorders that affect the heart or blood vessels. These include arrhythmias, aortic disease, congenital heart disease, heart attack, and others. Cardiac pacemakers are electric activity-generating devices that are used to treat patients suffering from cardiovascular diseases.For instance, in October 2024, according to the Centers for Disease Control, a US-based government agency, in 2023, approximately 919,032 people died from cardiovascular disease, accounting for 1 in every 3 deaths. Therefore, the rising incidence of cardiovascular diseases will drive the growth of the cardiac pacemaker industry.

Key Players In The Global Cardiac Pacemakers Market

Major companies operating in the cardiac pacemakers market are Medtronic plc, Abbott Inc, Boston Scientific Corporation, Biotronik SE & Co. KG, Lepu Medical Technology Co. Ltd, MicroPort Scientific Corporation, LivaNova PLC, Zoll Medical Corporation, Oscor Inc, Osypka Medical GmbH, Cardionovum GmbH, Shree Pacetronix Limited, Medico SpA, CCC Medical Devices, Galix Biomedical Instrumentation, Vimecon GmbH, Mediana Co. Ltd, Cardioline SpA, Pacetronix India Pvt Ltd, Beijing Universal Pacing Technology Co. Ltd

Global Cardiac Pacemakers Market Trends and Insights

Major companies operating in the cardiac pacemaker market are developing innovative products, such as i2i communication technology, which enables real-time communication between the two devices. i2i (infrastructure-to-infrastructure) communication technology enables seamless data exchange between different infrastructure systems, improving automation and operational efficiency. For instance, in November 2023, Abbott Laboratories, a US-based medical device company, launched the AVEIR DR System to treat patients with abnormal or slow heart rhythms. This innovative dual-chamber leadless pacemaker system offers synchronized pacing for both the right atrium and ventricle, ensuring proper heart rhythm. It is implanted through a minimally invasive procedure, reducing recovery time and complications. Advanced implant-to-implant technology allows real-time communication between the devices, coordinating effective pacing. This technology represents a breakthrough in heart health management.

What Are Latest Mergers And Acquisitions In The Cardiac Pacemakers Market?

In November 2024, Merit Medical Systems, Inc., a US-based medical device company, acquired the lead-management portfolio from Cook Medical for approximately US$210 million. Through this acquisition, Merit aims to strengthen its electrophysiology and cardiac rhythm-management business by integrating Cook Medical’s comprehensive portfolio of devices and accessories used in pacemaker and ICD lead management procedures. Cook Medical’s lead-management business is a US-based provider of medical devices and accessories for the removal or replacement of pacemaker and implantable cardioverter-defibrillator (ICD) leads.

Regional Outlook

North America was the largest region in the cardiac pacemakers market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Cardiac Pacemakers Market?

The cardiac pacemaker market consists of sales of single chamber, dual chamber and Biventricular pacemakers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.